NCT03229980View on ClinicalTrials.gov

Pediatric Myocardial Protection With Potassium Cardioplegia

PHASE2CompletedINTERVENTIONAL
Enrollment

87

Participants

Timeline

Start Date

August 10, 2017

Primary Completion Date

April 3, 2018

Study Completion Date

April 28, 2018

Conditions
Cardioplegia
Interventions
DRUG

Cold blood cardioplegia (large volume)

Hearts will be arrested with cold blood cardioplegia, first dose (arrest dose) will be 30 ml/kg and the frequent doses every 20 min will be 15 ml/kg

DRUG

Cold blood cardioplegia (small volume)

Hearts will be arrested with cold blood cardioplegia first dose (arrest dose) will be 10 ml/kg and the frequent doses every 20 min will be 5 ml/kg

Trial Locations (1)

Unknown

Faculty of Medicine, Asyut

All Listed Sponsors
lead

Assiut University

OTHER

NCT03229980 - Pediatric Myocardial Protection With Potassium Cardioplegia | Biotech Hunter | Biotech Hunter